Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

32.25
Delayed Data
As of Dec 05
 +1.20 / +3.86%
Today’s Change
20.07
Today|||52-Week Range
34.06
+14.00%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close31.05
Today’s open31.49
Day’s range31.03 - 32.31
Volume242,021
Average volume (3 months)266,904
Market cap$1.1B
Dividend yield--
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+58.04%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio161.3
Price/Sales11.37
Price/Book8.66

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+1.23+4.68%
SUPNSupernus Pharmaceuti...+0.40+1.83%
PTLAPortola Pharmaceutic...+0.64+3.57%
IPXLImpax Laboratories I...-0.25-1.83%
Data as of 12/05/2016

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs